All Editorial articles – Page 183
-
NewsChatGPT failed when challenging ESCMID guideline for treating brain abscesses
A new study has found that while ChatGPT seems able to give recommendations on key questions about diagnosis and treatment of brain abscesses in most cases, some of the AI model’s responses could put patients at risk.
-
NewsCervical cancer vaccine very effective in reducing HPV-related disease, but huge variations between countries in coverage
Although evidence is clear that HPV vaccination is reducing cervical cancer incidence and mortality and HPV-related disease, there are high variations in coverage globally, including among high-income countries.
-
NewsNonalcoholic fatty liver disease: changes in gut microbiota and blood lipids
This study aimed to explore differences in the gut microbial community and blood lipids between normal livers and those affected by NAFLD using 16S ribosomal deoxyribonucleic acid sequencing.
-
NewsBioinformatics professor discovers surprising evolutionary pattern in landmark yeast study
A new study challenges accepted frameworks within which yeast evolution is studied and provide access to an incredibly rich yeast analysis dataset that could have major implications for future evolutionary biology and bioinformatics research.
-
NewsExperts developing immune-enhancing therapies to target tuberculosis
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body’s own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.
-
NewsNew tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
NewsGut microbiome continually evolves as pregnancy progresses
A new study reveals the patterns of microbial dysbiosis associated with different pregnancy complications, providing an theoretical basis for elucidating the baseline characteristics of the microbiome in pregnant women.
-
NewsChlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and those identifying as Black or multiracial
A recent study of individuals ages 15 to 60 has found that nearly one in five patients with chlamydia and one in four patients with gonorrhea did not receive CDC recommended treatment for their infection.
-
NewsEnterovirus paralysis is a serious threat and surveillance and testing systems are desperately needed
Poliomyelitis (polio) has been eliminated in almost all countries of the world - yet non-polio enteroviruses can also lead to the same devastating symptoms of ‘acute flaccid paralysis’ (AFP).
-
NewsLower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.
-
NewsReview probes gel formation mechanisms and the role of lactic acid bacteria in fermented sausage
Researchers have reviewed the process of gel formation in fermented sausages, emphasizing the crucial role of myofibrillar proteins and the influence of lactic acid bacteria, temperature, and processing methods on gel properties.
-
NewsStudy confirms effectiveness of bivalent COVID-19 vaccine
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a new study.
-
NewsScientists replace fishmeal in aquaculture with microbial protein from soybean processing wastewater
Scientists have successfully replaced half the fishmeal protein in the diets of farmed Asian seabass with a ‘single cell protein’ cultivated from microbes in soybean processing wastewater, paving the way for more sustainable fish farming.
-
NewsTreatment for deadly superbug C. diff may be weakening
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research.
-
NewsScientists deploy synthetic amyloids to figure out ways of targeting biofilms
New research being presented at the Letters in Applied Microbiology ECS Research Symposium this May will reveal how scientists are investigating how macrophages can be used to break down amyloid plaques in biofilms.
-
NewsMaking transfusion-transmitted malaria in Europe a thing of the past
The current strategy used in Europe to mitigate malaria transfusion risk is efficient with just 10 reported cases over the past 20 years, but current serological tests used to identify “at risk” donors are not sensitive enough to completely eliminate the risk.
-
NewsCocktails of antibiotics, probiotics and prebiotics hold promise in treating a common form of irritable bowel syndrome
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), a new study suggests.
-
NewsExperts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)
Scientists show how the latest CRISPR-Cas gene editing technology can be used to help modify and attack AMR bacteria.
-
NewsCRISPR is promising to tackle antimicrobial resistance - but remember bacteria can fight back
Experts are looking to use the Nobel winning technology to target resistance genes and make bacteria sensitive to first line antibiotics again; but the bacteria have ways to fight back.
-
NewsExperimental NIH malaria monoclonal antibody protective in Malian children
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial.